Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Atrial Fibrillation | Research

Changes in estimated glomerular filtration rate before and after the first visit for atrial fibrillation

Authors: Ryobun Yasuoka, Hiroyuki Sakurane, Mana Okune, Motohide Tanaka, Tomoya Nagano, Masahiro Maruyama, Gaku Nakazawa, Takashi Kurita

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Although the development of atrial fibrillation (AF) and the progression of chronic kidney disease are known to be interrelated, it remains unclear when and how renal function changes during the clinical course of AF.

Methods

This study retrospectively enrolled 131 patients who were able to collect data on estimated glomerular filtration rate (eGFR) at least five times during the 500 days before and 500 days after the first visit (baseline) of new-onset AF, respectively. To investigate the temporal relationship between the development of AF and the beginning of worsening renal function (WRF), a piecewise regression model was applied to the eGFR time series data. The time point at which the slopes of the two regression lines changed (inflection -point), the slope before and after the inflection-point (β1 and β2, respectively), and the difference in slope (Δβ) were estimated. The presence of WRF was defined as having the inflection-point at which both Δβ and β2 were < − 0.0083 mL/min/1.73 m2/day (corresponding to 3.03 mL/min/1.73 m2/year), and the corresponding the inflection-point was defined as the beginning of WRF.

Results

WRF was detected in 54 (41.2%) patients. The beginning of WRF were distributed at various times, but most frequently (23 of 54 patients) within 100 days before and after baseline. The presence of WRF was not associated with age, heart failure, or baseline eGFR, but was associated with positive β1 (odds ratio 30.5, 95% confidence interval 11.1–83.9, P < 0.01).

Conclusion

In nearly half of AF patients with WRF, the beginning of WRF was observed within a few months before or after the first visit for AF. Patients with a positive eGFR slope before the onset of AF are more likely to develop WRF after the onset of AF, suggesting that potential kidney damage may be underlying.
Literature
1.
go back to reference Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal Disease in adults with chronic Kidney Disease. Circulation. 2013;127(5):569–74.CrossRefPubMed Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal Disease in adults with chronic Kidney Disease. Circulation. 2013;127(5):569–74.CrossRefPubMed
2.
go back to reference Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Chronic Renal Insufficiency Cohort (CRIC) Study Group, et al. Chronic Kidney Disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC). Am Heart J. 2010;159(6):1102–7.CrossRefPubMedPubMedCentral Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Chronic Renal Insufficiency Cohort (CRIC) Study Group, et al. Chronic Kidney Disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC). Am Heart J. 2010;159(6):1102–7.CrossRefPubMedPubMedCentral
3.
go back to reference Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic Kidney Disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009;158(4):629–36.CrossRefPubMed Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic Kidney Disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009;158(4):629–36.CrossRefPubMed
4.
go back to reference Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, et al. Changes in renal function in patients with Atrial Fibrillation: an analysis from the RE-LY trial. J Am Coll Cardiol. 2015;65(23):2481–93.CrossRefPubMed Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, et al. Changes in renal function in patients with Atrial Fibrillation: an analysis from the RE-LY trial. J Am Coll Cardiol. 2015;65(23):2481–93.CrossRefPubMed
5.
go back to reference Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, et al. ORBIT AF patients and investigators. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Heart. 2020;106(5):358–64.CrossRefPubMed Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, et al. ORBIT AF patients and investigators. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Heart. 2020;106(5):358–64.CrossRefPubMed
6.
go back to reference Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, et al. The SAKURA AF Registry investigators. Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy. Curr Med Res Opin. 2019;35(11):2007–13.CrossRefPubMed Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, et al. The SAKURA AF Registry investigators. Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy. Curr Med Res Opin. 2019;35(11):2007–13.CrossRefPubMed
7.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed
8.
go back to reference Seber GAF, Wild CJ. Nonlinear regression. New York, New York, USA: John Wiley and Sons; 1989.CrossRef Seber GAF, Wild CJ. Nonlinear regression. New York, New York, USA: John Wiley and Sons; 1989.CrossRef
9.
go back to reference Judith D, Toms. Lesperance. Piecewise Regression: A Tool for identifying ecological thresholds. Ecology. 2003;84(8):2034–41.CrossRef Judith D, Toms. Lesperance. Piecewise Regression: A Tool for identifying ecological thresholds. Ecology. 2003;84(8):2034–41.CrossRef
10.
go back to reference Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008;168(20):2212–8.CrossRefPubMedPubMedCentral Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008;168(20):2212–8.CrossRefPubMedPubMedCentral
11.
go back to reference Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20(12):2625–30.CrossRefPubMedPubMedCentral Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20(12):2625–30.CrossRefPubMedPubMedCentral
12.
go back to reference Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting Stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.CrossRefPubMed Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting Stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.CrossRefPubMed
13.
go back to reference Kidney Disease. Improving global outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276. Kidney Disease. Improving global outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276.
14.
go back to reference Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, et al. Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep. 2016;6:30271.CrossRefPubMedPubMedCentral Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, et al. Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep. 2016;6:30271.CrossRefPubMedPubMedCentral
15.
go back to reference Miyamoto K, Aiba T, Arihiro S, Watanabe M, Kokubo Y, Ishibashi K, et al. Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart Vessels. 2016;31(8):1327–36.CrossRefPubMed Miyamoto K, Aiba T, Arihiro S, Watanabe M, Kokubo Y, Ishibashi K, et al. Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart Vessels. 2016;31(8):1327–36.CrossRefPubMed
16.
go back to reference Hu L, Xiong Q, Chen Z, Fu L, Hu J, Chen Q, Tu W, Xu C, Xu G, Li J, Hong K. Factors Associated with a large decline in renal function or progression to renal insufficiency in hospitalized Atrial Fibrillation patients with early-stage CKD. Int Heart J. 2020;61(2):239–48.CrossRefPubMed Hu L, Xiong Q, Chen Z, Fu L, Hu J, Chen Q, Tu W, Xu C, Xu G, Li J, Hong K. Factors Associated with a large decline in renal function or progression to renal insufficiency in hospitalized Atrial Fibrillation patients with early-stage CKD. Int Heart J. 2020;61(2):239–48.CrossRefPubMed
17.
go back to reference Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, et al. CRIC Study. Atrial fibrillation and risk of ESRD in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1189–96.CrossRefPubMedPubMedCentral Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, et al. CRIC Study. Atrial fibrillation and risk of ESRD in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1189–96.CrossRefPubMedPubMedCentral
18.
go back to reference Friedman HS, O’Connor J, Kottmeier S, Shaughnessy E, McGuinn R. The effects of atrial fibrillation on regional blood flow in the awake dog. Can J Cardiol. 1987;3(5):240–5.PubMed Friedman HS, O’Connor J, Kottmeier S, Shaughnessy E, McGuinn R. The effects of atrial fibrillation on regional blood flow in the awake dog. Can J Cardiol. 1987;3(5):240–5.PubMed
19.
go back to reference Pruijm M, Milani B, Pivin E, Podhajska A, Vogt B, Stuber M, Burnier M. Reduced cortical oxygenation predicts a Progressive decline of renal function in patients with chronic Kidney Disease. Kidney Int. 2018;93(4):932–40.CrossRefPubMed Pruijm M, Milani B, Pivin E, Podhajska A, Vogt B, Stuber M, Burnier M. Reduced cortical oxygenation predicts a Progressive decline of renal function in patients with chronic Kidney Disease. Kidney Int. 2018;93(4):932–40.CrossRefPubMed
20.
go back to reference Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for Disease. N Engl J Med. 1995;332(10):647–55.CrossRefPubMed Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for Disease. N Engl J Med. 1995;332(10):647–55.CrossRefPubMed
21.
go back to reference Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol. 2004;15(5):1277–88.CrossRefPubMed Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol. 2004;15(5):1277–88.CrossRefPubMed
22.
go back to reference Norman JT, Stidwill R, Singer M, Fine LG. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron Physiol. 2003;94(2):39–46.CrossRef Norman JT, Stidwill R, Singer M, Fine LG. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron Physiol. 2003;94(2):39–46.CrossRef
23.
go back to reference Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV. PARADIGM-HF and ATMOSPHERE investigators and committees. Type of Atrial Fibrillation and outcomes in patients with Heart Failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(20):2490–500.CrossRefPubMed Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV. PARADIGM-HF and ATMOSPHERE investigators and committees. Type of Atrial Fibrillation and outcomes in patients with Heart Failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(20):2490–500.CrossRefPubMed
24.
go back to reference Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int. 2003;63(3):1027–36.CrossRefPubMed Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int. 2003;63(3):1027–36.CrossRefPubMed
25.
go back to reference Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the Progressive nature of Kidney Disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of Progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal Disease. N Engl J Med. 1982;307(11):652–9.CrossRefPubMed Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the Progressive nature of Kidney Disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of Progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal Disease. N Engl J Med. 1982;307(11):652–9.CrossRefPubMed
26.
go back to reference Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152(9):561–7.CrossRefPubMedPubMedCentral Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152(9):561–7.CrossRefPubMedPubMedCentral
28.
go back to reference Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal Disease. Kidney Int. 2003;63(4):1468–74.CrossRefPubMed Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal Disease. Kidney Int. 2003;63(4):1468–74.CrossRefPubMed
Metadata
Title
Changes in estimated glomerular filtration rate before and after the first visit for atrial fibrillation
Authors
Ryobun Yasuoka
Hiroyuki Sakurane
Mana Okune
Motohide Tanaka
Tomoya Nagano
Masahiro Maruyama
Gaku Nakazawa
Takashi Kurita
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03449-y

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.